Literature DB >> 8270864

The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.

M J Reddehase1, M Balthesen, M Rapp, S Jonjić, I Pavić, U H Koszinowski.   

Abstract

Recurrence of cytomegalovirus (CMV) from latency is a frequent cause of disease in immunocompromised patients. To date, there is no explanation for the diversity in the clinical manifestations. Primary infection can occur perinatally or later in life, and inevitably results in latent infection. Seropositivity for antibodies against CMV is indicative of latent infection, but is insufficient as a predictor for the risk of recurrence. As a model for this important medical problem, we compared the risks of murine CMV recurrence from latency established after neonatal primary infection and after infection at adult age. The risk of CMV recurrence was high only after neonatal infection. The copy number of latent viral genome in tissues was identified as the key parameter that determines the overall and organ-specific risks of recurrence. Latent CMV burden and risk of recurrence were related to the extent of virus multiplication during primary infection. The presence of latent CMV in multiple organs provides the molecular basis for stochastic events of recurrence in single organs or in any combination thereof. These findings are discussed as a concept of multifocal CMV latency and recurrence. It provides a rationale for the diversity in the clinical outcome of CMV disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8270864      PMCID: PMC2191331          DOI: 10.1084/jem.179.1.185

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

Review 1.  The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses.

Authors:  B Roizmann; R C Desrosiers; B Fleckenstein; C Lopez; A C Minson; M J Studdert
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus.

Authors:  G M Keil; M R Fibi; U H Koszinowski
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

3.  Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.

Authors:  M J Reddehase; F Weiland; K Münch; S Jonjic; A Lüske; U H Koszinowski
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

4.  Transmission of latent cytomegalovirus in a murine kidney tissue transplantation model.

Authors:  J D Hamilton; B J Seaworth
Journal:  Transplantation       Date:  1985-03       Impact factor: 4.939

5.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

6.  Mouse cytomegalovirus. Necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infection.

Authors:  D Henson; A J Strano
Journal:  Am J Pathol       Date:  1972-07       Impact factor: 4.307

7.  Primary cytomegalovirus infection following cardiac transplantation in a murine model.

Authors:  R H Rubin; E J Wilson; L V Barrett; D N Medearis
Journal:  Transplantation       Date:  1984-03       Impact factor: 4.939

8.  Lungs are a major organ site of cytomegalovirus latency and recurrence.

Authors:  M Balthesen; M Messerle; M J Reddehase
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

Review 9.  Latent infection and the elusive cytomegalovirus.

Authors:  M C Jordan
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr

10.  Modification by adoptive humoral immunity of murine cytomegalovirus infection.

Authors:  J D Shanley; M C Jordan; J G Stevens
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

View more
  105 in total

1.  Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution.

Authors:  M Wagner; S Jonjic; U H Koszinowski; M Messerle
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs.

Authors:  N K Grzimek; D Dreis; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency.

Authors:  A T Hoge; S B Hendrickson; W H Burns
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).

Authors:  R Holtappels; J Podlech; N K Grzimek; D Thomas; M F Pahl-Seibert; M J Reddehase
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype.

Authors:  Rafaela Holtappels; Doris Thomas; Jürgen Podlech; Matthias J Reddehase
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs.

Authors:  R Holtappels; M F Pahl-Seibert; D Thomas; M J Reddehase
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Early establishment of gamma-herpesvirus latency: implications for immune control.

Authors:  Emilio Flaño; Qingmei Jia; John Moore; David L Woodland; Ren Sun; Marcia A Blackman
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

8.  Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.

Authors:  Irena Slavuljica; Andreas Busche; Marina Babić; Maja Mitrović; Iva Gašparović; Durđica Cekinović; Elitza Markova Car; Ester Pernjak Pugel; Ana Ciković; Vanda Juranić Lisnić; William J Britt; Ulrich Koszinowski; Martin Messerle; Astrid Krmpotić; Stipan Jonjić
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

9.  Immunosuppression induces transcription of murine cytomegalovirus glycoprotein H in the eye and at non-ocular sites.

Authors:  Y Duan; S S Atherton
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Lymphoid-tissue stromal cells coordinate innate defense to cytomegalovirus.

Authors:  Shilpi Verma; Qiao Wang; Grzegorz Chodaczek; Chris A Benedict
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.